TotalMarketCap

Viatris

VTRSNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$20.261 B

$17.64 +1.15%

Close of 12 Oct 2026

As of 12 Oct 2026, Viatris (VTRS) has a market capitalization of $20.3B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$14.3B

#313 by revenue

Earnings

—

Not reported

Shares outstanding

1,148,590,864

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →
  1. #23Genmab A/SGMAB$23.1B
  2. #24InsmedINSM$22.0B
  3. #25ViatrisVTRS$20.3B
  4. #26Ascendis Pharma A/SASND$15.1B
  5. #27Jazz PharmaceuticalsJAZZ$14.2B

What if Viatris were worth as much as…

Open the what-if tool →

Gold $29.0T

$25,269.80

Per share 1,433× higher

Bitcoin $1.66T

$1,447.84

Per share 82.1× higher

Nvidia $5.53T

$4,810.81

Per share 273× higher

Or at a round number

$50.0B$100.0B$200.0B$500.0B

Where these numbers come from

Share counts and financials for Viatris are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 13 Oct 2026. Read the methodology.